| Literature DB >> 27014286 |
Zoltán Bozsó1, Péter G Ott1, Evelin Kámán-Tóth1, Gábor F Bognár1, Miklós Pogány1, Ágnes Szatmári1.
Abstract
In this study transcriptomic alterations of bacterially induced pattern triggered immunity (PTI) were compared with other types of tobacco-Pseudomonas interactions. In addition, using pharmacological agents we blocked some signal transduction pathways (Ca(2+) influx, kinases, phospholipases, proteasomic protein degradation) to find out how they contribute to gene expression during PTI. PTI is the first defense response of plant cells to microbes, elicited by their widely conserved molecular patterns. Tobacco is an important model of Solanaceae to study resistance responses, including defense mechanisms against bacteria. In spite of these facts the transcription regulation of tobacco genes during different types of plant bacterial interactions is not well-described. In this paper we compared the tobacco transcriptomic alterations in microarray experiments induced by (i) PTI inducer Pseudomonas syringae pv. syringae type III secretion mutant (hrcC) at earlier (6 h post inoculation) and later (48 hpi) stages of defense, (ii) wild type P. syringae (6 hpi) that causes effector triggered immunity (ETI) and cell death (HR), and (iii) disease-causing P. syringae pv. tabaci (6 hpi). Among the different treatments the highest overlap was between the PTI and ETI at 6 hpi, however, there were groups of genes with specifically altered activity for either type of defenses. Instead of quantitative effects of the virulent P. tabaci on PTI-related genes it influenced transcription qualitatively and blocked the expression changes of a special set of genes including ones involved in signal transduction and transcription regulation. P. tabaci specifically activated or repressed other groups of genes seemingly not related to either PTI or ETI. Kinase and phospholipase A inhibitors had highest impacts on the PTI response and effects of these signal inhibitors on transcription greatly overlapped. Remarkable interactions of phospholipase C-related pathways with the proteasomal system were also observable. Genes specifically affected by virulent P. tabaci belonged to various previously identified signaling routes, suggesting that compatible pathogens may modulate diverse signaling pathways of PTI to overcome plant defense.Entities:
Keywords: Pseudomonas syringae; compatible interaction; effector triggered immunity (ETI); pattern triggered immunity (PTI); signal transduction; tobacco; transcriptome
Year: 2016 PMID: 27014286 PMCID: PMC4779890 DOI: 10.3389/fpls.2016.00251
Source DB: PubMed Journal: Front Plant Sci ISSN: 1664-462X Impact factor: 5.753
Number of significantly activated or repressed genes after different bacterial treatments.
| 278 | 269 | 87 | 101 | |
| 288 | 295 | Nd | Nd | |
| 297 | 296 | Nd | Nd | |
| 230 | 263 | Nd | Nd | |
Criteria for gene selection are described in the text. Gene activity changes were compared to water-infiltrated samples;
By 48 hpi P. syringae-infiltrated tissues were collapsed;
Not determined.
Figure 1Comparison of the intensity and directions of gene expression changes induced by different treatments. The X- and Y axes show average log2 transcription activation or repression of those genes of the given treatments that both are differentially expressed when compared to the water-injected control. (A) P. syringae hrcC (PTI) at 6 h post-inoculation (hpi) vs. P. syringae (ETI) at 6 hpi. (B) P. syringae hrcC (PTI) at 6 hpi vs. P. syringae hrcC (PTI) at 48 hpi. (C) P. syringae (ETI) at 6 hpi vs. P. tabaci (compatible) at 6 hpi. (D) P. syringae hrcC (PTI) at 6 hpi vs. P. tabaci (compatible) at 6 hpi. Points in quadrants 2 and 3 shows those genes activated and repressed in the same direction by both treatments, respectively. Points in quadrants 1 and 4 shows those genes that were activated and repressed in the opposite direction in the two treatments. Figure shows results of the average of triplicates.
Figure 2Number and direction of expression changes induced by different bacterial treatments. (A–C) Number of common and specific genes significantly up- or down-regulated after inoculations. Area-proportional Venn diagrams were produced with help of BioVenn (Hulsen et al., 2008) (D) Cluster analysis of transcriptomic alterations induced by different bacterial treatments. Genes appearing in cluster 1 are affected mostly by PTI and ETI at 6 hpi. Some of the genes here are up- or down regulated exclusively during PTI at 6 hpi. Cluster 2 contains genes that are specific mainly to ETI at 6 hpi. Group 3 includes specific genes of late (48 hpi) PTI. Most of the genes belonging to cluster 4 were activated in all samples irrespective of the type of bacterial treatment. Cluster 5 represents genes that changed their transcription at 6 hpi regardless of the type of the treatment. Group 6 contains activated or repressed genes induced by living pathogens with functional Type III secretion system (either ETI inducible P. syringae or compatible P. tabaci). In cluster 7 there are genes whose transcription was specifically modulated by compatible disease causing P. tabaci. Genes belonging to cluster 8 were repressed in all samples irrespective of the type of bacterial treatment. Red and green colors represent up- or down regulation of genes compared to water infiltrated control, respectively.
Gene enrichment results of up-regulated ETI specific genes at 6 hpi (.
| GO:0009611 | Response to wounding | 11 | 1.80E-05 |
| GO:0010200 | Response to chitin | 11 | 5.00E-05 |
| GO:0002679 | Respiratory burst during defense response | 6 | 0.00028 |
| GO:0050832 | Defense response to fungus | 8 | 0.001 |
| GO:0009693 | Ethylene biosynthetic process | 5 | 0.0034 |
| GO:0034976 | Response to endoplasmic reticulum stress | 7 | 0.0058 |
| GO:0043069 | Negative regulation of programmed cell death | 5 | 0.0084 |
| GO:0009867 | Jasmonic acid mediated signaling pathway | 6 | 0.0099 |
| GO:0009414 | Response to water deprivation | 7 | 0.012 |
| GO:0000165 | MAPKKK cascade | 5 | 0.016 |
| GO:0009409 | Response to cold | 8 | 0.022 |
| GO:0010363 | Regulation of plant-type hypersensitive response | 6 | 0.027 |
| GO:0009862 | Systemic acquired resistance, salicylic acid mediated signaling pathway | 5 | 0.028 |
| GO:0009738 | Abscisic acid mediated signaling pathway | 5 | 0.028 |
| GO:0006612 | Protein targeting to membrane | 6 | 0.031 |
| GO:0006633 | Fatty acid biosynthetic process | 5 | 0.046 |
| GO:0005886 | Plasma membrane | 30 | 0.00012 |
| GO:0055044 | Symplast | 9 | 0.028 |
| GO:0009506 | Plasmodesma | 9 | 0.028 |
| GO:0005794 | Golgi apparatus | 9 | 0.043 |
| GO:0005774 | Vacuolar membrane | 6 | 0.049 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
GO terms highlighted with gray background were specific to ETI at 6 hpi.
Possible localization of the gene product(s).
Gene enrichment results of up-regulated PTI specific genes at 6 hpi (.
| GO:0009651 | Response to salt stress | 14 | 1.60E-06 |
| GO:0046686 | Response to cadmium ion | 11 | 2.60E-06 |
| GO:0034976 | Response to endoplasmic reticulum stress | 9 | 1.30E-05 |
| GO:0009627 | Systemic acquired resistance | 9 | 7.60E-05 |
| GO:0042542 | Response to hydrogen peroxide | 7 | 0.00018 |
| GO:0006094 | Gluconeogenesis | 6 | 0.00018 |
| GO:0006096 | Glycolysis | 5 | 0.004 |
| GO:0006972 | Hyperosmotic response | 5 | 0.0066 |
| GO:0009414 | Response to water deprivation | 6 | 0.0084 |
| GO:0009408 | Response to heat | 5 | 0.012 |
| GO:0009611 | Response to wounding | 5 | 0.019 |
| GO:0006499 | N-terminal protein myristoylation | 6 | 0.021 |
| GO:0005783 | Endoplasmic reticulum | 13 | 3.10E-07 |
| GO:0005886 | Plasma membrane | 26 | 1.20E-05 |
| GO:0005774 | Vacuolar membrane | 10 | 1.20E-05 |
| GO:0055044 | Symplast | 11 | 0.00012 |
| GO:0009506 | Plasmodesma | 11 | 0.00012 |
| GO:0048046 | Apoplast | 7 | 0.00088 |
| GO:0005829 | Cytosol | 11 | 0.018 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
GO terms highlighted with gray background were specific to PTI at 6 hpi.
Possible localization of the gene product(s).
Gene enrichment results of down-regulated ETI specific genes at 6 hpi (.
| GO:0019684 | Photosynthesis, light reaction | 7 | 0.0015 |
| GO:0009637 | Response to blue light | 5 | 0.0015 |
| GO:0006833 | Water transport | 5 | 0.0025 |
| GO:0007030 | Golgi organization | 5 | 0.004 |
| GO:0009651 | Response to salt stress | 9 | 0.005 |
| GO:0019252 | Starch biosynthetic process | 5 | 0.005 |
| GO:0006364 | rRNA processing | 6 | 0.0053 |
| GO:0015674 | di-, tri-valent inorganic cation transport | 6 | 0.0053 |
| GO:0044262 | Cellular carbohydrate metabolic process | 13 | 0.0077 |
| GO:0009658 | Chloroplast organization | 5 | 0.0082 |
| GO:0016071 | mRNA metabolic process | 6 | 0.0088 |
| GO:0015672 | Monovalent inorganic cation transport | 5 | 0.0088 |
| GO:0051186 | Cofactor metabolic process | 8 | 0.011 |
| GO:0009266 | Response to temperature stimulus | 9 | 0.011 |
| GO:0030001 | Metal ion transport | 7 | 0.011 |
| GO:0010035 | Response to inorganic substance | 9 | 0.022 |
| GO:0008654 | Phospholipid biosynthetic process | 5 | 0.047 |
| GO:0009639 | Response to red or far red light | 5 | 0.047 |
| GO:0044271 | Cellular nitrogen compound biosynthetic process | 7 | 0.048 |
| GO:0009535 | Chloroplast thylakoid membrane | 9 | 1.60E-06 |
| GO:0009570 | Chloroplast stroma | 11 | 2.70E-06 |
| GO:0009941 | Chloroplast envelope | 8 | 0.00061 |
| GO:0016021 | Integral to membrane | 7 | 0.035 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
GO terms highlighted with gray background were specific to ETI at 6 hpi.
Possible localization of the gene product(s).
Gene enrichment results of down-regulated PTI specific genes at 6 hpi (.
| GO:0009773 | Photosynthetic electron transport in photosystem I | 5 | 2.90E-06 |
| GO:0006098 | Pentose-phosphate shunt | 7 | 2.90E-06 |
| GO:0019344 | Cysteine biosynthetic process | 6 | 2.60E-05 |
| GO:0015994 | Chlorophyll metabolic process | 5 | 0.00024 |
| GO:0010027 | Thylakoid membrane organization | 5 | 0.00026 |
| GO:0055080 | Cation homeostasis | 5 | 0.00038 |
| GO:0019288 | Isopentenyl diphosphate biosynthetic process, mevalonate-independent pathway | 5 | 0.00046 |
| GO:0030001 | Metal ion transport | 5 | 0.02 |
| GO:0010038 | Response to metal ion | 5 | 0.026 |
| GO:0009535 | Chloroplast thylakoid membrane | 11 | 5.20E-11 |
| GO:0009570 | Chloroplast stroma | 10 | 3.20E-07 |
| GO:0043234 | Protein complex | 8 | 0.0092 |
| GO:0009941 | Chloroplast envelope | 5 | 0.014 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
GO terms highlighted with gray background were specific to PTI at 6 hpi.
Possible localization of the gene product(s).
Signaling and protein degradation associated genes up- or down-regulated at 6 hpi specifically in ETI (.
| STMHW88 | Receptor-like protein kinase | |
| STMJG46 | Receptor-like protein kinase | |
| STMIR02 | Receptor-like serine/threonine kinase | |
| STMJC66 | Protein kinase | |
| STMJA91 | Calreticulin precursor | |
| STMIO40 | NtEIG-E80 protein, PAR1, PAR1 protein | |
| STMIR07 | Protein kinase | |
| STMGL52 | S-receptor kinase | |
| STMEG05 | EF-hand, calcium binding motif | |
| STMHY91 | EF-hand, calcium binding motif | |
| STMJH49 | EF-hand, calcium binding motif | |
| STMGY49 | Extra-large G-protein-like | |
| STMIL12 | Phytochrome A signal transduction 1 | |
| STMJF72 | Phytochrome A signal transduction 2 | |
| STMIV50 | GTP-binding protein-related | |
| STMEF62 | GTP-binding protein-related | |
| STMJL27 | GTP-binding protein-related | |
| STMHJ24 | Autophagy 7 [ | |
| STMHR44 | Arm repeat-containing protein | |
| STMHK80 | Cucumisin-like serine protease | |
| STMCX90 | Serin carboxypeptidase-like protein | |
| STMDZ53 | Ubiquitin domain | |
| STMFA02 | Ubiquitin interaction motif-containing protein | |
| STMGU22 | Zinc finger (C3HC4-type RING finger) family protein | |
| STMID28 | Zinc finger (C3HC4-type RING finger) family protein | |
| STMGU22 | Zinc finger (C3HC4-type RING finger) family protein | |
| STMCE77 | F-box family protein | |
| STMCY90 | UBX domain-containing protein | |
| STMCJ34 | Cysteine protease precursor | |
| STMDG47 | Pre-pro-cysteine proteinase precursor | |
| STMEU11 | Cathepsin B-like cysteine proteinase | |
| STMJB45 | Cathepsin B-like cysteine proteinase | |
| STMDM72 | CLP proteinase like protein | |
Gene selection was done by MAPMAN classification. Red and green colors represent up- or down-regulated genes, respectively. Gene expressions are in log.
EST identifier of NCBI EST database (.
Gene expression in log.
Figure 3Pie chart representing percent ratios of putative function-based groups of tobacco genes up or down-regulated during PTI and blocked by compatible . 47 PTI activated or repressed tobacco genes were blocked by living P. tabaci at 6 hpi. Functional classification of genes was determined by the help of MAPMAN (Rotter et al., 2007). Based on the identified putative functions genes were classified into 14 groups: peroxidases, photosynthesis/chloroplast, cell wall synthesis/degradation, lipid metabolism, amino acid metabolism, secondary metabolism/phenylpropanoids, stress/defense-related, redox state, detoxification, signal/transcriptional regulation, proteases, transport, other no homology. Corresponding percentages are demonstrated in the figure.
Gene enrichment results of up-regulated PTI genes at 6 hpi (.
| GO:0050832 | Defense response to fungus | 5 | 0.00087 |
| GO:0009627 | Systemic acquired resistance | 5 | 0.0022 |
| GO:0009753 | Response to jasmonic acid stimulus | 5 | 0.0026 |
| GO:0031347 | Regulation of defense response | 5 | 0.0039 |
| GO:0023052 | Signaling | 9 | 0.0053 |
| GO:0055114 | Oxidation reduction | 7 | 0.0053 |
| GO:0006810 | Transport | 11 | 0.0058 |
| GO:0005618 | Cell wall | 5 | 0.013 |
| GO:0005886 | Plasma membrane | 11 | 0.016 |
| GO:0005773 | Vacuole | 5 | 0.018 |
| GO:0005576 | Extracellular region | 9 | 0.018 |
| GO:0005794 | Golgi apparatus | 5 | 0.025 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
Possible localization of the gene product(s).
Gene enrichment results of down-regulated PTI genes at 6 hpi (.
| GO:0015979 | Photosynthesis | 5 | 0.00024 |
| GO:0009416 | Response to light stimulus | 5 | 0.0091 |
| GO:0005975 | Carbohydrate metabolic process | 6 | 0.014 |
| GO:0009579 | Thylakoid | 6 | 1.60E-05 |
| GO:0009941 | Chloroplast envelope | 6 | 1.60E-05 |
| GO:0005576 | Extracellular region | 6 | 0.026 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
Possible localization of the gene product(s).
Gene enrichment results of up-regulated genes that were specifically activated by compatible .
| GO:0009738 | Abscisic acid mediated signaling pathway | 8 | 2.50E-05 |
| GO:0042538 | Hyperosmotic salinity response | 6 | 0.00014 |
| GO:0009414 | Response to water deprivation | 7 | 0.0018 |
| GO:0019748 | Secondary metabolic process | 11 | 0.0037 |
| GO:0006732 | Coenzyme metabolic process | 7 | 0.0049 |
| GO:0055086 | Nucleobase, nucleoside and nucleotide metabolic process | 8 | 0.0068 |
| GO:0046483 | Heterocycle metabolic process | 9 | 0.014 |
| GO:0006066 | Alcohol metabolic process | 9 | 0.028 |
| GO:0044255 | Cellular lipid metabolic process | 10 | 0.029 |
| GO:0009814 | Defense response, incompatible interaction | 6 | 0.032 |
| GO:0048519 | Negative regulation of biological process | 9 | 0.044 |
| GO:0005829 | Cytosol | 15 | 0.00057 |
| GO:0005737 | Cytoplasm | 43 | 0.016 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
Possible localization of the gene product(s).
Gene enrichment results of down-regulated genes that were specifically repressed by compatible .
| GO:0000165 | MAPKKK cascade | 6 | 3.50E-05 |
| GO:0016117 | Carotenoid biosynthetic process | 5 | 3.50E-05 |
| GO:0010114 | Response to red light | 5 | 3.50E-05 |
| GO:0015995 | Chlorophyll biosynthetic process | 5 | 5.30E-05 |
| GO:0009862 | Systemic acquired resistance, salicylic acid mediated signaling pathway | 6 | 5.90E-05 |
| GO:0031348 | Negative regulation of defense response | 6 | 7.80E-05 |
| GO:0009867 | Jasmonic acid mediated signaling pathway | 6 | 7.80E-05 |
| GO:0010103 | Stomatal complex morphogenesis | 5 | 7.80E-05 |
| GO:0006364 | rRNA processing | 6 | 0.00013 |
| GO:0010207 | Photosystem II assembly | 5 | 0.00013 |
| GO:0010310 | Regulation of hydrogen peroxide metabolic process | 5 | 0.00014 |
| GO:0050832 | Defense response to fungus | 6 | 0.00014 |
| GO:0010027 | Thylakoid membrane organization | 5 | 0.00015 |
| GO:0010363 | Regulation of plant-type hypersensitive response | 6 | 0.00019 |
| GO:0032268 | Regulation of cellular protein metabolic process | 5 | 0.00021 |
| GO:0006612 | Protein targeting to membrane | 6 | 0.00022 |
| GO:0009409 | Response to cold | 7 | 0.00022 |
| GO:0019288 | Isopentenyl diphosphate biosynthetic process, mevalonate-independent pathway | 5 | 0.00022 |
| GO:0010200 | Response to chitin | 6 | 0.00023 |
| GO:0009627 | Systemic acquired resistance | 6 | 0.00031 |
| GO:0042742 | Defense response to bacterium | 5 | 0.0016 |
| GO:0044275 | Cellular carbohydrate catabolic process | 5 | 0.0052 |
| GO:0018193 | Peptidyl-amino acid modification | 5 | 0.0079 |
| GO:0009117 | Nucleotide metabolic process | 5 | 0.012 |
| GO:0071554 | Cell wall organization or biogenesis | 5 | 0.044 |
| GO:0009535 | Chloroplast thylakoid membrane | 9 | 3.20E-09 |
| GO:0009570 | Chloroplast stroma | 8 | 6.60E-06 |
| GO:0048046 | Apoplast | 6 | 9.60E-05 |
| GO:0005618 | Cell wall | 6 | 0.00082 |
| GO:0005840 | Ribosome | 5 | 0.0024 |
| GO:0009941 | Chloroplast envelope | 5 | 0.0042 |
Number of genes associated with the GO term.
FDR<0.05 were selected as significant enrichment.
GO terms highlighted with gray background were terms that were over-represented in ETI at 6 hpi (up-regulated ETI specific genes in Table .
Possible localization of the gene product(s).
Figure 4Comparison of the intensity and directions of gene expression changes caused by various signal inhibitors on PTI-related genes at 6 hpi. X-axes show average log2 transcription activation or repression of PTI-related genes compared to water-injected control (up- or down-regulated in P. syringe hrcC infiltrated leaves). Y axes show changes caused by signal inhibitors on PTI-related genes (P. syringe hrcC+signal inhibitors) compared to P. syringe hrcC (PTI)-injected samples. (A) LaCl2, Ca2+ channel blocker (B) neomycin, phospholipase C/D inhibitor (C) aristolochic acid, phospholipase A inhibitor. (D) K252a, kinase inhibitor (E) MG115, proteasome inhibitor. Points in quadrants 2 and 3 show those genes activated and repressed in the same direction in both treatments, respectively. Points in quadrants 1 and 4 show those genes that were activated and repressed in the opposite direction in the two treatments. Figure shows results of the average of triplicates.
Figure 5Effect of different signaling inhibitors on PTI-related gene expression. (A) Expression pattern of PTI-related genes after infiltration together with various signal pathway inhibitors. First column shows transcription of 99 PTI-related genes at 6 hpi in plant leaves after infiltration with P. syringe hrcC and compared to water-infiltrated control. Other columns show effects of different signaling pathway inhibitors on the expression of these PTI-related genes. Red and green colors represent up- or down regulation of genes compared to control, respectively. Genes were ranked manually and coloration was carried out by using FiRe 2.2 program. Different letters on the right side of figure mark groups of genes that show similar pattern of expression. (A) Genes whose expression was altered by all inhibitors. (B) PTI-related genes whose expression was not affected by aristolochic acid but influenced by other inhibitors to varying extent. (C) PTI-related genes whose expression was influenced mainly by neomycin and MG115. (D) PTI-related genes whose expression was affected by both aristolochic acid and K252a. (E) PTI-related genes whose expression was influenced by both K252a and MG115. (F–J) Groups represent genes whose expression is influenced by only one inhibitor. (B) Interactions between different signal inhibitors in PTI-related gene expressions. Circles represent the used signal inhibitors. Sizes of the circles are proportional to the number of the PTI-related genes influenced by the given inhibitors. Thicknesses of lines between circles are proportional to the number of commonly affected genes, which is indicated with numbers on the line as well. (C) Relationships between the effects of different inhibitors on PTI-related gene expressions. Table shows interactions of various signaling pathways during transcriptional regulation of PTI genes. Data presents the number of genes commonly affected by the inhibitors at 6 hpi after infiltration with P. syringe hrcC. Orange part of table shows the number of genes that the inhibitors transcriptionally modified to the same direction, while green part of the table shows number of genes modified in opposite directions. Inhibitors were the following: LaCl2, Ca2+ channel blocker; neomycin, phospholipase C and D inhibitor; aristolochic acid, phospholipase A inhibitor; K252a, kinase inhibitor; MG115, proteasome inhibitor.